去纤苷在中国上市了吗？哪里买？

The drug developed by Italy's Gentium Pharmaceuticals was launched in the United States in 2016 and is mainly used to treat hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS). So, has defibrotide been launched in China? Where to buy?

Many patients don’t know where to buy defibrotide drugs. In fact, defibrotide is not yet on the market in China. Patients cannot buy this drug in hospital pharmacies, let alone use medical insurance for reimbursement. So can this medicine only be purchased abroad? In fact, in addition to purchasing overseas drugs abroad, you can also obtain them through domestic professional overseas medical service institutions. Medical Travel is a relatively professional overseas medical service organization that can help patients obtain defibrotide.

The medicines obtained through Medical Companion Travel are all sent directly from pharmaceutical manufacturers, which can be guaranteed to be genuine and cost-effective. It can not only save the trouble of going abroad to purchase medicines, but also save patients a considerable financial burden. Patients only need to consult the medical companion service staff about the drug purchase process and price. After confirming the purchased drugs, they can wait at home. However, the prices of overseas drugs are constantly changing due to exchange rate fluctuations. Patients can consult the medical companion and passenger service staff for the price of a box of defibrotide. Of course, if financial conditions permit, patients can also go abroad to buy medicines, but they must go to local regular hospital pharmacies to avoid buying fake medicines. The editor does not recommend that patients obtain drugs through purchasing agents, as it is easy to be deceived.

Defibrotide is the first drug approved by the United States for the treatment of severe hepatic venule occlusion, a rare and fatal liver disease. It is also currently recognized as the most promising new drug for the treatment of hepatic veno-occlusive disease (HOVD) after hematopoietic stem cell transplantation (HSCT). The side effects of defibrotide are usually mild, and patients only need to take the medication as directed by their doctor. The drug is a mixture of single-stranded oligonucleotides with anti-thrombotic and fibrinolytic effects. Patients should note that defibrinoside can cause hypersensitivity reactions. Patients should pay more attention to their own reactions when taking the drug to avoid serious hypersensitivity reactions and aggravation of the original condition.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: